Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 29th January 2024 Vol. No. 13 ; Issue No.615
Publications

1. Patwardhan RS, Gohil D, Singh B, Kumar BK, Purohit V, Thoh M, Checker R, Gardi N, Gota V, Kutala VK, Patwardhan S, Sharma D, Sandur SK (2024). Mitochondrial-targeted curcumin inhibits T-cell activation via Nrf2 and inhibits graft-versus-host-disease in a mouse model. Phytotherapy Research.

2. Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, Singh A, Peelay Z, Chakraborty S, Jadhav M, Alone M, Bhagyavant P, Kolkur M, Srinivas S, Das S, Roy S, Mandal T, Dsouza H, Saha S, Rai R, Srikanth A, Shah D, Khan A, Muthuluri H, Kumar A, Agarwal A, Rajpurohit A, Goli V, Sekar A, Mantri A, Kanteti A, Majumdar S, Khaddar S, Shenoy R, Elamarthi P, Rathnaswamy N, Kashyap L, Abraham G, Booma N, Simha V, Chaukar D, Pai P, Nair S, Laskar S, Nawale K, Naidu P, Salian S, Shelar P, Raulo R, Dhumal S, Prabhash K (2024).Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. European Journal of Cancer. 200: 113560.

3. McLeod M, Torode J, Leung K, Bhoo-Pathy N, Booth C, Chakowa J, Gralow J, Ilbawi A, Jassem J, Parkes J, Mallafré-Larrosa M, Mutebi M, Pramesh CS, Sengar M, Tsunoda A, Unger-Saldaña K, Vanderpuye V, Yusuf A, Sullivan R, Aggarwal A (2024). Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study. Lancet Oncology. 25(2): e63-e72.

4. Gupta SK, Gohil D, Momin MB, Yadav S, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Hingorani L, Khattry N, Gota V (2024). Withania somnifera extract mitigates experimental acute graft versus host disease without abrogating graft versus leukemia effect. Cell Transplantation. 33: 9636897241226573.

5. Vasundhara P, Nagaraju P (2024). Impact of balanced lifestyles on childhood development: A study at crèche. Journal of Addiction Therapy and Research. 8:1-8.

6. Ranade M, Epari S, Shetty O, Dhanavade S, Chavan S, Sahay A, Sahu A, Shetty P, Moiyadi A, Singh V, Dasgupta A, Chatterjee A, Kannan S, Gupta T (2024). CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization. Journal of Neuro-oncology.

7. Manjali J, Keluskar Geyata, Patel Ruchi, Bano N, Shaikh F, Malhotra R, Mani S, Kumar A, Sinha S, Krishnamurthy R, Dasgupta A, Chatterjee A, Tibdewal A, Pathak R, Mummudi N, Wadasadwala T, Laskar S, Sarin R, Agarwal JP, Gupta T (2024). Validation testing of OUTPATSAT-35RT questionnaire to assess satisfaction in patients on outpatient radiotherapy in a large Indian cohort. Journal of Cancer Research and Therapeutics.

8. Rashid M, Rashid R, Gadewal N, Carethers J, Koi M, Brim H, Ashktarab H (2024). High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer. Neoplasia. 49: 100970.

Site of the Week

Protein Clusters is a collection of related protein sequences (clusters) consists of proteins derived from the annotations of whole genomes, organelles and plasmids.

desktop Image
Interesting Reads

Scott MT, Liu W, Mitchell R, Clarke CJ, Kinstrie R, Warren F, Almasoudi H, Stevens T, Dunn K, Pritchard J, Drotar ME, Michie AM, Jørgensen HG, Higgins B, Copland M, Vetrie D. Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease. Nature Communications. 15(1): 651.

Video of the Week
Systemic and Local Immune Dynamics in Cancer Immunotherapy
Upcoming Events
An Asia Pacific Cell Therapy Conference and Hands-on Workshop Series SACT-2024

Febraury 1 - 3, 2024

At CIDCO Exhibition Centre, Navi Mumbai

3rd International Global Cancer Consortium Conference

February 3 - 5, 2024

At ACTREC,TMC, Navi Mumbai

6th Indian Cancer Genetics Conference & Workshop

February 21 – 25 , 2024

At ACTREC,TMC, Navi Mumbai

Do You Know?

In 1975, Köhler and Milstein developed methods for producing antibodies by fusing cultured myeloma cells with normal B cells from immunized mice.

back Image
Cancer News
Study unlocks new immunological pathway for treating breast cancer bone metastases.

MedicalXpress, 24/01/2024

Researchers have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients. They discovered a unique glyco-immune checkpoint axis in bone metastases that involves a protein called sialic...

Researchers develop nanofiber-based drug delivery system for skin cancer

Phys.org, 24/01/2024

The researchers employed various innovative research methods in developing a smart DDS against skin cancer. Overcoming the solubility barrier of anticancer drugs is crucial and is achieved by coating them with suitable materials for better release...

Study suggests that unintentional weight loss is a signal to see a doctor.

Sciencedaily, 23/01/2024

The study assessed 157,474 participants in two large longitudinal studies: the Nurses' Health Study, which enrolled nurses aged 30 to 55 starting in 1976, and the Health Professionals Follow-Up Study, which enrolled male health professionals aged 40 to 75 years starting in 1986...

2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)